搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
11 天
on MSN
Is micro-dosing Ozempic really a side effect free way to lose weight?
Is micro-dosing Ozempic really a side effect free way to lose weight? - The latest buzz around the popular weight loss drugs ...
3 天
Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB ...
Detailed price information for Corbus Pharmaceuticals Hldgs Inc (CRBP-Q) from The Globe and Mail including charting and trades.
12 天
Lexaria's Registered GLP-1 Study #4 Begins Dosing
Registered Phase-1b 12-week study will investigate safety, diabetes control, and weight loss KELOWNA, BC / ACCESSWIRE / ...
Business Insider
11 天
Lexaria Bioscience’s Phase 1b study starts patient dosing, says H.C. Wainwright
H.C. Wainwright reiterates a Buy rating and $10 price target on Lexaria Bioscience (LEXX) shares after the company announced that the Phase 1b 12-week chronic study in Australia has started patient ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈